Whitepapers

Our whitepapers provide information on advanced medicines, their clinical implementation and process for regulatory approval, the science and technologies that support them, the engineered systems used for their manufacture and distribution, the engagement of communities needing these therapies, and the economic models that enable affordable access.

Choose to download one or more at your convenience.

whitepaper

Distributive Manufacturing of CD19 CAR-T Cells Using CliniMACS Prodigy: Feasibility and Real-World Experience from India

Download

whitepaper

A place-of-care approach to CAR-T cell manufacturing

Download

whitepaper

Global Access to Human Gene Therapy: Lessons Learned from HIV

Download

whitepaper

Centralized vs Decentralized Manufacturing of Personalized Cell Therapies: How to Implement Local Manufacturing of CAR T-Cells

Download

whitepaper

Regulatory Considerations for Decentralized Manufacturing of Personalized Cell Therapies: A Path Forward for Commercialization of Decentralized Manufacturing of CAR-T Cell Therapies

Download

whitepaper

Centralized vs Decentralized Manufacturing of Personalized Cell Therapies: CAR-T cell Product Manufacture, Quality and Release

Download

whitepaper

Centralized vs Decentralized Manufacturing of Personalized Cell Therapies: Overview and Logistics

Download

whitepaper

Introduction to Chimeric Antigen Receptor (CAR) engineered immune cells

Download